Results 111 to 120 of about 13,685 (176)

Similarity-Based Profiling of Hydrazone-Containing Scaffolds Active Against <i>Leishmania</i> Amastigotes. [PDF]

ACS Omega
Pereira da Silva RY, Alves de Lima JL, Pinto SBA, I LC, Jordão AK, Barbosa EG.   +5 more
europepmc   +1 more source

Hit-Identification to Novel Antileishmanial Agents from a β‑Pinene Scaffold: from Synthesis to <i>In Vitro</i> Evaluation and <i>In Silico</i> SAR/ADMET Profiling. [PDF]

ACS Omega
Martins GDS, M da S Santos B, Emiliano YSS, Santos JPA, Machado GM, de Carvalho MS, Sette KM, Rodrigues IA, T de Souza AM, Torres-Santos EC, G Finelli F, Leal ICR.   +11 more
europepmc   +1 more source

New Copper (II) Complexes Based on 1,4-Disubstituted-1,2,3-Triazole Ligands with Promising Antileishmanial Activity. [PDF]

Pharmaceutics
Nascimento JPC, Faganello NL, Freitas KF, Pinto LMC, das Neves AR, Carvalho DB, Arruda CCP, Silva SM, Almeida RCF, Júnior AM, Back DF, Pizzuti L, Saba S, Rafique J, Baroni ACM, Casagrande GA.   +15 more
europepmc   +1 more source

Stage-Specific Expression and Subcellular Localization of Calcineurin in Infective Forms of <i>Leishmania amazonensis</i>. [PDF]

Pathogens
Brandt-Almeida D, Sauter IP, Cruz MC, Cortez C, Orrego PR, Cortez M.   +5 more
europepmc   +1 more source

Light, Dyes, and Action: Photodynamic Inactivation of <i>Leishmania amazonensis</i> Using Methylene Blue, New Methylene Blue, and Novel Ruthenium-Based Derivatives. [PDF]

Biology (Basel)
Vasco-Dos-Santos DR, Vacani-Martins N, Silva FCMD, Alves LA, Rocha ZND, Henriques-Pons A, Torres-Santos EC, Vannier-Santos MA.   +7 more
europepmc   +1 more source

infection impairs dendritic cell migration from the inflammatory site to the draining lymph node [PDF]

core   +1 more source

Leishmania amazonensis infection induces PD-L1 expression on dendritic cells and impairs Th1 responses in vitro and in vivo. [PDF]

Sci Rep
de Matos Guedes HL, da Fonseca-Martins AM, Liang Y, Carlsen ED, Henard CA, Pinchuk IV, Soong L.   +6 more
europepmc   +1 more source

Beyond the Skin: Topical Amphotericin B Nanocarriers Targeting Cutaneous Leishmaniasis with Suppression of Lymphatic Parasite Burden. [PDF]

Infect Dis Rep
Alexandrino-Júnior F, Barcellos G, Gonçalves-Oliveira LF, Côrtes LMC, Souza-Silva F, Alves CR, Dias-Lopes G, Peixoto JF, Patricio BFC, Rocha HVA.   +9 more
europepmc   +1 more source

Unleashing the immune modulatory potential of <i>Leishmania amazonensis-</i>derived extracellular vesicles in American cutaneous leishmaniasis. [PDF]

Front Mol Biosci
de Freitas BE, Rodrigues A, Palma-Marques J, Weber JI, Valério-Bolas A, Soares RP, Torrecilhas AC, Ferla M, Muhammad Abdel Baqui M, Gonzales Cordova RA, Alexandre-Pires G, Pereira da Fonseca I, de Andrade HM, Santos-Gomes G.   +13 more
europepmc   +1 more source

Pentamidine-Functionalized Polycaprolactone Nanofibers Produced by Solution Blow Spinning for Controlled Release in Cutaneous Leishmaniasis Treatment. [PDF]

Polymers (Basel)
Guembe-Michel N, Nguewa P, González-Gaitano G.   +2 more
europepmc   +1 more source